Cardiovascular risk profile assessment in glucose-intolerant Asian individuals - An evaluation of the World Health Organization two-step strategy: The DECODA Study (Diabetes Epidemiology: Collaborative Analysis of Diagnostic Criteria in Asia)

Diabetic Medicine

Volumn 19, Issue 7, 2002, Pages 549-557

  Tuomilehto, Jaakko ^a   Borch Johnsen, Knut ^a   Tajima, Naoko ^a   Cockram, Clive S ^a   Nakagami, Tomoko ^a  

^a STENO DIABETES CENTER   (Denmark)

Author keywords

Asia; Cardiovascular risk; Diabetes; Diagnostic criteria; Screening

Indexed keywords

CHOLESTEROL; GLUCOSE;

ADULT; AGED; ARTICLE; ASIAN; BLOOD PRESSURE MEASUREMENT; BODY MASS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIAGNOSTIC VALUE; DIET RESTRICTION; EPIDEMIOLOGICAL DATA; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; IMPAIRED GLUCOSE TOLERANCE; MAJOR CLINICAL STUDY; MALE; MASS SCREENING; NON INSULIN DEPENDENT DIABETES MELLITUS; POPULATION RESEARCH; RISK ASSESSMENT; RISK FACTOR; WORLD HEALTH ORGANIZATION;

ADULT; AGED; AGED, 80 AND OVER; ASIA; BLOOD GLUCOSE; DIABETIC ANGIOPATHIES; FEMALE; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; RISK ASSESSMENT; RISK FACTORS; WORLD HEALTH ORGANIZATION;

EID: 0036425093     PISSN: 07423071     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-5491.2002.00735.x     Document Type: Article

References (36)

1. World Health Organization. WHO Expert Committee on Diabetes Mellitus, Second Report, Technical Report Series 646. Geneva: World Health Organization, 1980.
2. Hanson RL, Nelson RG, Mccance DR, Beart JA, Charles MA, Pettitt DJ et al. Comparison of screening tests for non-insulin dependent diabetes mellitus. Arch Intern Med 1993; 27: 2133-2140.
3. Lee CH, Chong SF. Evaluation of fasting plasma glucose as a screening test for diabetes mellitus in Singaporean adults. Diabet Med 1996; 14: 119-122.
4. Expert committee on the diagnosis, classification of diabetes mellitus. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 1997; 20 (Suppl. 1): 1183-1197.
5. World Health Organization. Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications. Part 1: Diagnosis and Classification of Diabetes Mellitus. Report of a WHO Consultation. Geneva: World Health Organization, 1999: 1-59.
6. Li CL, Tsai ST, Chou P. Comparison of the results between two diagnostic criteria by ADA and WHO among subjects with FPG 5.6-7.8 mmol/l in Kin-Hu and Kin-Chen, Kinmen, 1991-94. Diabetes Res Clin Prac 1999; 45: 51-59.
7. Okubo M, Watanabe H, Fujikawa R, Kawamura T, Egusa G, Yamakido M. Reduced prevalence of diabetes according to 1997 American Diabetes Association criteria. Diabetologia 1999; 42: 1168-1170.
8. Gimeno SGA, Ferreira SRG, Franco LJ, Iunes M, the Japanese Brazilian Diabetes Study Group. Comparison of glucose tolerance categories according to World Health Organization and American Diabetes Association diagnostic criteria in a population-based study in Brazil. Diabetes Care 1998; 21: 1889-1892.
9. Tai ES, Lim SC, Tan BY, Chew SK, Heng D, Tan CE. Screening for diabetes - A two-step approach in individuals with impaired fasting glucose improves detection of those at risk of complications. Diabet Med 2000; 17: 771-775.
10. Tominaga M, Eguchi H, Manaka H, Igarashi K, Kato T, Sekikawa A. Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose. Diabetes Care 1999; 22: 920-924.
11. Barrett-Connor E, Ferrara A. Isolated postchallenge hyperglycaemia and the risk of fatal cardiovasular disease in older women and men. Diabetes Care 1998; 21: 1236-1239.
12. DECODE Study Group on behalf of the European Diabetes Epidemiology Study Group. Consequences of the new diagnostic criteria for diabetes in older men and women. Diabetes Care 1999; 22: 1667-1671.
13. Shaw JE, Hodge AM, De Courten M, Chitson P, Zimmet PZ. Isolated post-challenge hyperglycaemia confirmed as a risk factor for mortality. Diabetologia 1999; 42: 1050-1054.
14. Rewers M, Shetterly SM, Baxter J, Marshall JA, Hamman RF. Prevalence of coronary heart disease in subjects with normal and impaired glucose tolerance and non-insulin dependent diabetes mellitus in a biethnic Cororado population. Am J Epidemiol 1992; 135: 1321-1329.
15. DECODE Study Group on behalf of the European Diabetes Epidemiology Study Group. Glucose tolerance and cardiovascular mortality. Comparison of fasting and 2-hour diagnostic criteria. Arch Intern Med 2001; 161: 397-405.
16. DECODA Study Group on behalf of the International Diabetes Epidemiology Group. Comparison of the fasting and 2-hour glucose criteria for diabetes in different Asian cohorts. Diabetologia 2000; 43: 1470-1475.
17. DECODA Study Group on behalf of the International Diabetes Epidemiology Group. The fasting plasma glucose cut-point predicting a diabetic 2-hour OGTT glucose depends on the phenotype. Diabetes Res Clin Prac 2002; 55: 35-43.
18. DECODE Study Group on behalf of the European Diabetes Epidemiology Study Group. New diagnostic criteria for diabetes and mortality in older adults. Lancet 1999; 353: 68-69.
19. DECODE Study Group on behalf of the European Diabetes Epidemiology Study Group. Glucose tolerance and mortality: Comparison of WHO and American Diabetic Association diagnostic criteria. Lancet 1999; 354: 617-621.
20. De Vegt F, Dekker JM, Stehouwer CDA, Nijpels G, Bouter LM, Heine RJ. Similar 9-years mortality risks and reproducibility for the World Health Organization and American Diabetes Association glucose tolerance categories. Diabetes Care 2000; 21: 40-44.
21. DECODE Study Group on behalf of the European Diabetes Epidemiology Study Group. Will new diagnostic criteria for diabetes mellitus change phenotype of patients with diabetes? Reanalysis of European epidemiological data. BMJ 1998; 317: 371-375.
22. Unwin N, Alberti KGMM, Bhopal R, Harland J, Watson W, White M. Comparison of the current WHO and ADA criteria for the diagnosis of diabetes mellitus in three ethnic groups in the UK. Diabet Med 1998; 15: 554-557.
23. Shaw JE, Zimmet PZ, De Courten M, Dowse GK, Chitson P, Gareeboo H et al. Impaired fasting glucose or impaired glucose tolerance: What best predicts future diabetes in Mauritius? Diabetes Care 1999; 22: 399-402.
24. De Vegt F, Dekker JM, Jager A, Hienkens E, Kostense PJ, Stehouwer CDA et al. Relation of impaired fasting and postload glucose with incident type 2 diabetes in Dutch population: the Hoorn Study. JAMA 2001; 285: 2009-2013.
25. Pan XR, Li GW, Hu YH, Wang JX, Yang WY, An ZX et al. Effect of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and diabetes study. Diabetes Care 1997; 20: 537-544.
26. Eriksson KF, Lindgarde F. No excess 12 mortality in men with impaired glucose tolerance who participated in the Målmo Preventive Trial with diet and exercise. Diabetologia 1998; 41: 1010-1016.
27. Tuomilehto J, Lindstrom J, Eriksson JG, Valle TT, Hamalainen H, Iianne-Parikka P et al. for the Finnish Diabetes Prevention Study Group. Prevention of Type 2 diabetes by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001; 344: 1343-1350.
28. Dyson PA, Hammersley MS, Morris RJ, Holman RR, Turner RC. The Fasting Hyperglycaemia Study. II. Randomized controlled trial of reinforced healthy-living advice in subjects with increased but not diabetic fasting plasma glucose. Metabolism 1997; 46: 50-55.
29. Marques-Vidal P, Tuomilehto J. Hypertension awareness, treatment and control in the community: Is the 'rule of halves' still valid. J Human Hypertens 1997; 11: 213-220.
30. Mooy JM, Gootenhuis PA, de Vries H, Kostense PJ, Popp-Snijdeers C, Bouter LM et al. Intra-individual variation of glucose, specific insulin and proinsulin concentrations measured by two oral glucose tolerance tests in a general Caucasian population: the Hoorn study. Diabetologia 1996; 39: 298-305.
31. Feskens EJM, Bowles CH, Kromhout D. Intra- and inter-individual variability of glucose tolerance in an elderly population. J Clin Epidemiol 1991; 44: 947-953.
32. King H, Aubert RE, Herman WH. Global burden of diabetes, 1995-2025. Diabetes Care 1998; 21: 1414-1431.
33. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998; 352: 837-853.
34. UK Prospective Diabetes Study (UKPDS) Group. Tight blood pressure control and risk of macrovascular complications in type 2 diabetes (UKPDS 38). BMJ 1998; 317: 703-713.
35. Heart Outcomes Prevention Evaluation (HOPE) study investigators. Effect of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: Results from the HOPE study and MICRO-HOPE substudy. Lancet 1999; 355: 253-259.
36. Pyorala K, Pedersen TR, Kjekshus J, Faergeman O, Olsson AG, Thorgeirsson G, the Scandinavian Simvastatin Survival Study (4S) Group. Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease. A subgroup analysis of the Scandinavian Simvastatin Survival Study (4S). Diabetes Care 1997; 20: 614-620.